Flucloxacillin Export Market Intelligence: India's 123 Suppliers Shipping to 44 Countries — TransData Nexus 2026

Q: Who are the top flucloxacillin exporters from India?

The top flucloxacillin exporters from India are: 1. MEDREICH LIMITED — $19.6M (50.6% market share); 2. MICRO LABS LIMITED — $4.4M (11.5% market share); 3. KROSYL PHARMACEUTICALS PRIVATE LIMITED — $1.8M (4.7% market share); 4. MILAN LABORATORIES (INDIA) PRIVATE LIMITED — $1.7M (4.4% market share); 5. AUROBINDO PHARMA LTD — $1.7M (4.4% market share). Together they account for 75.5% of India's total flucloxacillin export value.

Q: What is the total export value of flucloxacillin from India?

The total export value of flucloxacillin from India is $38.8M USD, recorded across 1,146 shipment transactions from 123 active exporters to 44 destination countries. The average shipment value is $33.8K.

Q: Which countries import flucloxacillin from India?

India exports flucloxacillin to 44 countries worldwide. The top importing countries are: UNITED KINGDOM (36.4% share, $14.1M), AUSTRALIA (14.0% share, $5.4M), NETHERLANDS (10.1% share, $3.9M), SOUTH AFRICA (9.1% share, $3.5M), FINLAND (6.0% share, $2.3M). These five markets account for 75.7% of total export value.

Q: What is the average price of flucloxacillin exports from India?

The average unit price for flucloxacillin exports from India is $11.71 USD per unit, with prices ranging from $0.02 to $2683.28 depending on formulation, packaging, and order volume. The total market is valued at $38.8M across 1,146 shipments.

Q: Which ports handle flucloxacillin exports from India?

The primary ports for flucloxacillin exports from India are BANGALORE ICD (12.2% of shipments), BANGALORE ICD (INWFD6) (9.3% of shipments), NHAVA SHEVA SEA (INNSA1) (8.7% of shipments), JNPT (6.6% of shipments), BANGALORE ACC (INBLR4) (6.0% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of flucloxacillin?

India is one of the world's leading exporters of flucloxacillin due to its large base of 123 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports flucloxacillin to 44 countries, demonstrating 23% global market coverage.

Q: What certifications do Indian flucloxacillin exporters need?

Indian flucloxacillin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import flucloxacillin from India?

There are 198 registered buyers importing flucloxacillin from India, spread across 44 countries. The repeat buyer rate is 61.1%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top flucloxacillin supplier from India?

MEDREICH LIMITED is the leading flucloxacillin exporter from India with a market share of 50.6% and total export value of $19.6M across 337 shipments. The top 5 suppliers together control 75.5% of total export value.

Suresh Sormare

Flucloxacillin

India Pharmaceutical Trade Intelligence

$38.8M123 Suppliers44 CountriesHS 30041090

ExportsIndia → UNITED KINGDOM36.4%India → AUSTRALIA14.0%

ImportsAUSTRALIA → India$10.0K UNITED KINGDOM → India$8.9K

#1 Supplier: MEDREICH LIMITED #1 Buyer: MEDREICH PLC

Flucloxacillin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Flucloxacillin to the World

Between 2022 and 2026, India exported $38.8M worth of flucloxacillin across 1,146 verified shipments to 44 countries — covering 23% of world markets in the Advanced Antibiotics segment. The largest destination is UNITED KINGDOM (36.4%). MEDREICH LIMITED leads with a 50.6% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Flucloxacillin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Flucloxacillin export data snapshot — $38.8M · 123 exporters · 44 countriesTransData Nexus · Indian Customs Data

Top Flucloxacillin Exporters from India

123 active exporters · Ranked by export value

View all 123 →

Top Flucloxacillin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MEDREICH LIMITED	$19.6M	337	8	50.6%
2	MICRO LABS LIMITED

Top Countries Importing Flucloxacillin from India

44 destination markets · Ranked by import value

All 44 countries →

Top Countries Importing Flucloxacillin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED KINGDOM	$14.1M	36.4%
2	AUSTRALIA	$5.4M	14.0%
3	NETHERLANDS	$3.9M	10.1%
4	SOUTH AFRICA	$3.5M	9.1%
5	FINLAND	$2.3M	6.0%
6	CAMEROON	$2.2M	5.8%
7	PAPUA NEW GUINEA	$1.4M	3.7%
8	FRANCE	$1.3M	3.3%
9	MYANMAR	$632.6K	1.6%
10	KENYA	$508.0K	1.3%

UNITED KINGDOM is India's largest flucloxacillin export destination, absorbing 36.4% of total exports worth $14.1M. The top 5 importing countries — UNITED KINGDOM, AUSTRALIA, NETHERLANDS, SOUTH AFRICA, FINLAND — together account for 75.7% of India's total flucloxacillin export value. The remaining 39 destination countries collectively receive the other 24.3%, indicating a focused distribution strategy targeting key markets.

Who Supplies Flucloxacillin to India?

5 origin countries · Total import value: $19.4K

India imports flucloxacillin from 5 countries with a combined import value of $19.4K. The largest supplier is AUSTRALIA ($10.0K, 8 shipments), followed by UNITED KINGDOM and IRELAND. All values are from Indian Customs (DGFT) import records.

Countries Supplying Flucloxacillin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	AUSTRALIA	$10.0K	8	51.4%
2	UNITED KINGDOM	$8.9K	8	45.7%
3	IRELAND	$432	1	2.2%
4	SWEDEN	$108	1	0.6%
5	SOUTH AFRICA	$21	1	0.1%

AUSTRALIA is the largest supplier of flucloxacillin to India, accounting for 51.4% of total import value. The top 5 origin countries — AUSTRALIA, UNITED KINGDOM, IRELAND, SWEDEN, SOUTH AFRICA — together supply 100.0% of India's flucloxacillin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Flucloxacillin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, flucloxacillin does not have any approved Abbreviated New Drug Applications (ANDAs) listed in the FDA's Orange Book, indicating that it is not approved for marketing in the United States. Consequently, flucloxacillin is not included in the FDA's import alerts, which are mechanisms to prevent the entry of unapproved or non-compliant drugs into the U.S. market. This absence suggests that flucloxacillin is not actively imported or distributed within the United States.

Given the lack of FDA approval, Indian exporters aiming to enter the U.S. market would need to navigate the New Drug Application (NDA) or ANDA pathways, which involve comprehensive clinical trials and regulatory reviews to demonstrate safety and efficacy. The current exporter count of 123 indicates a robust production capacity in India; however, penetrating the U.S. market would require significant investment in regulatory compliance and market development strategies.

2EU & UK Regulatory Framework

In the European Union and the United Kingdom, flucloxacillin is subject to stringent regulatory oversight. The European Medicines Agency (EMA) has conducted periodic safety update report single assessments (PSUSAs) for flucloxacillin, with the most recent procedure (PSUSA/00001402/202003) resulting in a variation to the marketing authorization in January 2021. This variation underscores the importance of continuous pharmacovigilance and compliance with evolving regulatory requirements. (ema.europa.eu)

Manufacturers exporting to the EU and UK must adhere to Good Manufacturing Practice (GMP) standards as outlined by the EMA and the UK's Medicines and Healthcare products Regulatory Agency (MHRA). Compliance with these standards is critical to ensure product quality and safety, and non-compliance can lead to market withdrawal or suspension of marketing authorizations.

3WHO Essential Medicines & Global Standards

Flucloxacillin is included in the World Health Organization's (WHO) Model List of Essential Medicines, highlighting its importance in treating bacterial infections. The specific edition of the list should be consulted for the most current information. While flucloxacillin is not listed under the WHO Prequalification Programme, adherence to international pharmacopoeia standards such as the British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP) is essential for market acceptance and regulatory compliance.

4India Regulatory Classification

In India, flucloxacillin is classified under Schedule H of the Drugs and Cosmetics Rules, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) sets ceiling prices for essential medicines; however, the specific ceiling price for flucloxacillin should be verified with the latest NPPA notifications. For exports, manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national regulations and facilitating international trade.

5Patent & Exclusivity Status

Flucloxacillin is a well-established antibiotic with no active patents, allowing for generic competition. This lack of patent protection enables multiple manufacturers to produce and export flucloxacillin, contributing to the competitive landscape observed in India's export market.

6Recent Industry Developments

In October 2024, the EMA's Pharmacovigilance Risk Assessment Committee (PRAC) recommended updating the product information for paracetamol-containing products to include warnings about the risk of high anion gap metabolic acidosis (HAGMA) when used concomitantly with flucloxacillin. This recommendation emphasizes the need for healthcare professionals to exercise caution when prescribing these medications together. (ema.europa.eu)

In January 2021, the EMA issued a variation to the marketing authorization for flucloxacillin following a periodic safety update report single assessment (PSUSA/00001402/202003). This action reflects ongoing regulatory scrutiny and the importance of maintaining up-to-date safety information for medicinal products. (ema.europa.eu)

These developments highlight the dynamic nature of the pharmaceutical regulatory environment and the necessity for manufacturers and exporters to stay informed about regulatory changes to ensure compliance and market access.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Flucloxacillin

Retail & reference prices across 9 markets vs. India FOB export price of $11.71/unit

Global Price Benchmark for Flucloxacillin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	N/A	USD	Flucloxacillin is not approved by the U.S. Food and Drug Administration (FDA) and is therefore not available in the United States.
United Kingdom	N/A	GBP	Flucloxacillin is listed in the British National Formulary (BNF) and is available through the National Health Service (NHS).
Germany	N/A	EUR	Flucloxacillin is approved by the European Medicines Agency (EMA) and is available in Germany.
Australia	N/A

Supply Chain Risk Assessment — Flucloxacillin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Flucloxacillin, a penicillin-class antibiotic, is primarily manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) heavily relies on Key Starting Materials (KSMs) sourced from China. China controls approximately 70–80% of the global KSM supply and 60–70% of the global intermediate supply, making it a dominant player in this sector. This dependency exposes the supply chain to potential disruptions stemming from geopolitical tensions, trade restrictions, or environmental regulations affecting Chinese manufacturing facilities.

For instance, in 2018, environmental management efforts in China led to the closure of numerous factories producing KSMs, intermediates, and APIs, causing significant supply chain disruptions globally. Such events underscore the vulnerability of relying on a concentrated source for critical raw materials.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of flucloxacillin account for 75.5% of total exports, with MEDREICH LIMITED alone contributing 50.6%. This high supplier concentration poses a significant risk; any operational issues or regulatory actions affecting these key players could disrupt the global supply of flucloxacillin.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme aimed at boosting domestic production of critical APIs and reducing dependency on imports. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and 6-Aminopenicillanic Acid (6-APA), which are vital for producing antibiotics such as flucloxacillin. While this initiative is a positive step, its impact on reducing supplier concentration will take time to materialize.

Access Complete Flucloxacillin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 1,146 transactions across 44 markets.

Request Demo View Pricing

Frequently Asked Questions — Flucloxacillin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top flucloxacillin exporters from India?

The leading flucloxacillin exporters from India are MEDREICH LIMITED, MICRO LABS LIMITED, KROSYL PHARMACEUTICALS PRIVATE LIMITED, and 12 others. MEDREICH LIMITED leads with 50.6% market share ($19.6M). The top 5 suppliers together control 75.5% of total export value.

What is the total export value of flucloxacillin from India?

The total export value of flucloxacillin from India is $38.8M, recorded across 1,146 shipments from 123 active exporters to 44 countries. The average shipment value is $33.8K.

Which countries import flucloxacillin from India?

India exports flucloxacillin to 44 countries. The top importing countries are UNITED KINGDOM (36.4%), AUSTRALIA (14.0%), NETHERLANDS (10.1%), SOUTH AFRICA (9.1%), FINLAND (6.0%), which together account for 75.7% of total export value.

What is the HS code for flucloxacillin exports from India?

The primary HS code for flucloxacillin exports from India is 30041090. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Flucloxacillin

Flucloxacillin

Top Flucloxacillin Exporters from India

Top Countries Importing Flucloxacillin from India

Who Supplies Flucloxacillin to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Regulatory Landscape — Flucloxacillin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Flucloxacillin

Supply Chain Risk Assessment — Flucloxacillin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Flucloxacillin Trade Intelligence

Frequently Asked Questions — Flucloxacillin Exports from India

Who are the top flucloxacillin exporters from India?

What is the total export value of flucloxacillin from India?

Which countries import flucloxacillin from India?

What is the HS code for flucloxacillin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of flucloxacillin exports from India?

Which ports handle flucloxacillin exports from India?

Why is India a leading exporter of flucloxacillin?

What certifications do Indian flucloxacillin exporters need?

How many buyers import flucloxacillin from India?

What is the market share of the top flucloxacillin exporter from India?

Analysis Methodology